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Influenza A virus infection dysregulates the
expression of microRNA-22 and its targets;
CD147 and HDAC4, in epithelium of
asthmatics
Fatemeh Moheimani1,2* , Jorinke Koops1,2,3, Teresa Williams1,2,4, Andrew T. Reid1,2, Philip M. Hansbro1,2,
Peter A. Wark1,2,5 and Darryl A. Knight1,2,6
Abstract
Background: Specific microRNAs (miRNAs) play essential roles in airway remodeling in asthma. Infection with
influenza A virus (IAV) may also magnify pre-existing airway remodeling leading to asthma exacerbation. However,
these events remain to be fully defined. We investigated the expression of miRNAs with diverse functions including
proliferation (miR-20a), differentiation (miR-22) or innate/adaptive immune responses (miR-132) in primary bronchial
epithelial cells (pBECs) of asthmatics following infection with the H1N1 strain of IAV.
Methods: pBECs from subjects (n = 5) with severe asthma and non-asthmatics were cultured as submerged
monolayers or at the air-liquid-interface (ALI) conditions and incubated with IAV H1N1 (MOI 5) for up to 24 h.
Isolated miRNAs were subjected to Taqman miRNAs assays. We confirmed miRNA targets using a specific mimic
and antagomir. Taqman mRNAs assays and immunoblotting were used to assess expression of target genes and
proteins, respectively.
Results: At baseline, these miRNAs were expressed at the same level in pBECs of asthmatics and non-asthmatics.
After 24 h of infection, miR-22 expression increased significantly which was associated with the suppression of
CD147 mRNA and HDAC4 mRNA and protein expression in pBECs from non-asthmatics, cultured in ALI. In contrast,
miR-22 remained unchanged while CD147 expression increased and HDAC4 remained unaffected in cells from
asthmatics. IAV H1N1 mediated increases in SP1 and c-Myc transcription factors may underpin the induction of
CD147 in asthmatics.
Conclusion: The different profile of miR-22 expression in differentiated epithelial cells from non-asthmatics may
indicate a self-defense mechanism against aberrant epithelial responses through suppressing CD147 and HDAC4,
which is compromised in epithelial cells of asthmatics.
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Background
Airway remodelling in asthmatics is defined as structural
abnormalities including, epithelial integrity loss, base-
ment membrane thickening, and goblet cell and sub-
mucosal gland enlargement [1]. Airway remodelling may
predispose asthmatics to exacerbations [2]. The airway
epithelium consists of multiple distinct cell types; cili-
ated columnar, goblet, side population, serous and basal
cells [3]. Basal cells are capable of self-renewal and dif-
ferentiation into mucus-secreting and ciliated cells [4, 5].
The epithelium of asthmatics displays a greater propor-
tion of basal and fewer ciliated cells [6], suggesting dys-
regulated differentiation. Particularly in severe asthma,
increased epithelial proliferation contributes to thick-
ened epithelium and lamina reticularis and hence airway
narrowing [7, 8]. Dysregulated epithelial differentiation
therefore plays an important role in the remodelling
process in asthma. These abnormalities are also associ-
ated with functional aberrations including deficient in-
nate immune responses [3, 9, 10]. The innate immune
function of the epithelium is essential for defence against
inhaled pathogens such as viruses [3, 11–13]. The differ-
entiation state of the airway epithelium is also important
for innate immunity through the compartmentalization
of receptors and mediator production [4]. Consequently,
structural and functional abnormalities in the epithelium
may contribute to increased susceptibility of asthmatics
to noxious environmental stimuli, including respiratory
viruses (e.g. influenza A virus [IAV]).
The IAV H1N1 causes significant morbidity and mor-
tality in annual seasonal epidemics [14]. This virus dam-
ages the epithelium [15] and triggers inflammation and
cell signalling events resulting in additional airway re-
modelling and potentially exacerbations of asthma [14].
microRNAs (miRNAs) are small non-coding RNAs
which regulate the expression of up to 60% of human
genes [16]. Further, changes in specific miRNAs during
human airway epithelial cell differentiation regulates
gene and protein expression important for differenti-
ation [17]. miRNAs are hence crucial in most biological
and pathological processes [18, 19], including severe
asthma [20]. Some miRNAs, such as miR-20a from the
miR-17-92 cluster, promote the proliferation of lung epi-
thelial progenitor cells [21]. Whereas, others such as
miR-22, are differentiation specific and suppress differ-
ent genes responsible for cell proliferation [10, 22–24].
Several miRNAs are also associated with the regulation
of innate and adaptive immunity, including miR-132
[25, 26]. Consequently, miRNAs may play a major
role in phenotypic and functional abnormalities of
airway epithelial cells. IAV H1N1 infection is also
reported to dysregulate the expression of some miR-
NAs in human lung epithelial cells, affecting immune
responses [27, 28].
In this study, we hypothesized that the expression of
miRNAs responsible for proliferation, miR-20a, are ele-
vated, whereas miRNAs associated with differentiation,
miR-22, are down-regulated in airway epithelial cells of
asthmatics. These defects may form the link between ab-
normal airway epithelial cell differentiation and remodel-
ling. In addition, IAV H1N1 infection may further
dysregulate abnormalities in these miRNAs and hence
their targets in the airway epithelial cells of asthmatics.
Thus, we assessed the expression and role of these
miRNAs in the context of airway remodelling in primary
bronchoepithelial cells (pBECs) obtained from asthmatics,
cultured as monolayers or differentiated ALI conditions at
baseline level and after IAV H1N1 infection.
Methods
Cell culture
This study was approved by the Human Research Ethics
Committee of The University of Newcastle. Human
pBECs were obtained from non-asthmatics and adults
with severe or difficult to treat asthma based on inter-
national ERS/ATS guidelines [29] by endobronchial
brushing during fibre-optic bronchoscopy [30]. Donors
had no history of smoking. Non-asthmatics had no lung
disease and had normal lung function. See Table 1 for
patients’ demographics. All subjects gave written con-
sent. Experiments were conducted on cells at passage 2.
pBECs were cultured as submerged monolayers or at
ALI as previously described [31]. Experiments were car-
ried out on day 23–25 after raising cell culture to ALI
(Additional file 1: Figure S1). Minimally-immortalized
BECs (HBEC6-KT) were generously provided by Dr. John
Minna [32] and maintained in Keratinocyte Serum-Free
Media (KSFM; Invitrogen) with growth supplements and
antibiotics as described previously [33]. Madin-Darby
canine kidney (MDCK) cells (American Type Culture Col-
lection, USA) were maintained in Dulbecco’s modified Ea-
gle’s media with 5% fetal bovine serum [34].
IAV H1N1
Human IAV A/Auckland/1/2009 (H1N1) strain was ob-
tained from the WHO Collaborating Centre for Refer-
ence and Research on Influenza (Victoria, Australia).
IAV H1N1 was propagated and titrated in MDCK cells
[12, 13, 35]. The titer of virus stock was determined by
plaque assay on MDCK cells [34]. Ultra-violet (UV)
inactivation of live viruses was achieved by placing
live viruses directly under UV lamp (254 nm) for 2 h
[12, 13, 35]. Successful inactivation was confirmed by
plaque assays.
Cell viability
IAV H1N1 was diluted in serum free KSFM media and
added to HBEC6-KT cultured as monolater at a multiplicity
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of infection (MOI) of 0.5, 1, 5, 10 and 20. After 1 h of incu-
bation, inocula were removed and replaced with serum-free
media for 24 h. Cell viability was assessed by lactate de-
hydrogenase release [36] at 24 h post infection.
IAV H1N1 infection
IAV H1N1 was diluted in the appropriate serum free
media and added to pBECs cultured at monolayer or to
apical surface of ALI culture, at MOI of 5 [12, 13, 35].
After 1 h or 6 h of incubation of cells cultured under
monolayers or ALI conditions, respectively, the inocula
were removed and replaced with serum-free media. At
0, 1, 4, 6 and 24 h post inoculation of pBECs cultured as
monolayers or 0, 6, 8 and 24 h post infection of pBECs
cultured at ALI, miRNAs and mRNAs were isolated
using RNAeasy Mini Kit (Qiagen, USA) using 100%
instead of 70% ethanol, proteins were lysed [33], and
media were collected and stored at − 80 °C. Viral
infection was confirmed by plaque assay using MDCK
cells [34].
Cell transfection
HBEC6-KT cells or pBECs were seeded at 1 × 105 cell
per well in 24-well plates 24 h before transfection. Cells
were transfected, as described previously [37], with
miR-22 mimic, miRNA mimic negative control (mir-
Vana), miR-22 inhibitor, or miRNA inhibitor negative
control (mirVana) at 5 nM total concentration using
Lipofectamine® RNAiMAX Transfection Reagent (invi-
trogen) in Opti-MEM Medium (Gibco).
RT-qPCR
miRNA (100 ng) or mRNA (200 ng) were reverse tran-
scribed to cDNA, using Taqman MicroRNA Reverse
Transcription reagent or High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems). Predeveloped
primer/probe sets were purchased from Applied Biosys-
tems (TaqMan miRNA assays or TaqMan gene assays).
The quantitative fluorogenic amplification of cDNA
(RT-qPCR) was performed using an ABI 7500 Real Time
PCR (Applied Biosystems) or Eppendorf RealPlex
(Eppendorf) instruments, respectively. RNU44 (based on
manufacturer’s recommendations (Applied Biosystem)
and previous reports [38, 39]) or ribosomal RNA (18S)
[40, 41] was used as the reference miRNA or gene, re-
spectively. The cycle threshold (Ct) value obtained was
normalized to that of the RNU44 or 18S gene (ΔCt).
Data were expressed as 2-ΔΔCt [42] where ΔΔCt was
calculated from subtracting individual ΔCt from ΔCt of
non-asthmatic media control at baseline.
Immunoblotting
pBECs were lysed in RIPA buffer, and all proteins were
standardized to 5 μg and were resolved by SDS-PAGE,
and transferred onto nitrocellulose membranes for
detection of CD147, histone deacetylase (HDAC) 4,
MMP-9, c-Myc and SP1 (Abcam, UK), in cell lysates.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
was detected as a loading control for proteins in cell ly-
sates [12, 13]. Protein estimation was determined by
densitometry, using Image lab software (version 4.1),
and values were expressed as protein/GAPDH ratio and
normalized to media controls at baseline from pBEC of
non-asthmatics. All antibodies used in this study are
commercially available and have been validated by the
source company.
Gelatin zymography
Activity of MMP-9 released from pBECs into basal
media of cells cultured at ALI was assessed by gelatin
zymography, as previously described [43], with the
following modifications. Four times nonreducing loading
buffer was used and samples (20 μg) were resolved in
10% ready zymogram gels (BioRad). Gels were electro-
phoresed at 125 V for 90 min at 4 °C. The developing
buffer consisted of 50 mM Tris, 200 nM NaCl, 5 mM
CaCl2 (anhydrous), 0.02% Brij-35 and adjusted to
pH 7.5; the staining buffer consisted of 40% methanol,
10% acetic acid and 0.5% Coomassie Blue R-250, and;
the destaining solution consisted of 40% methanol and
10% acetic acid. Gelatin-degrading MMP-9 enzyme was
identified as clear zones of lysis against a blue back-
ground. Molecular masses of gelatinolytic bands were
estimated using prestained molecular mass markers;
Table 1 Donor demographics
Characteristics Healthy controls Asthmatics P Value
n 14 14 NA
Sex (M/F) 3/11 6/8 0.2
Mean age (SD), yr 58.1 (10.3) 54.7 (15.0) 0.5
Mean FEV1% predicted (SD) 100.1 (14.5) 60.7 (23.4) < 0.0001
FEV1:FVC ratio (SD) 80.4 (3.5) 59.3 (12.4) < 0.0001
Inhaled corticosteroid, % treated 0 100 NA
Atopy 0 7 < 0.05
Definition of abbreviations: NA, not applicable. The statistical analysis used for this table was using unpaired T-test with Welch’s correction
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precision plus protein standard (BioRad). Activities in
the gel were determined by densitometry, using Image
lab software (version 4.1).
Statistical analysis
Data were expressed as mean ± standard error of mean
(SEM). Nonparametric test was used for pair-wise com-
parisons, and Kruskal Wallis nonparametric multiple
comparisons test was used for comparison of group data
when non-normally distributed. A two-way analysis of
variance with Bonferroni post-test was used for compari-
son of group data when normally distributed. A p-value
of ≤ 0.05 was considered significant.
Results
Morphological and physical properties of monolayer and
ALI cultures of pBECs from non-asthmatics and
asthmatics
In order to assess and compare the expression of miR-
NAs in homogenous populations of pBECs [44], we
cultured cells in monolayer culture (Additional file 1:
Figure S1A-B) as well as ALI culture, where cells differ-
entiate and form cilia and secrete mucus which is
more representative of the pseudostratified structure
(Additional file 1: Figure S1C-D). We observed no morpho-
logical difference between pBECs from non-asthmatics and
asthmatics in monolayer culture. pBECs from both non-
asthmatics and asthmatics formed differentiated, multi-
layered ALI cultures, also with no obvious histological
differences between them (Additional file 1: Figure S1C-D).
In cells cultured at ALI, the formation of junctional com-
plexes was indirectly confirmed by measurement of transe-
pithelial electrical resistance (TEER) every 7 days, using
World Precision Instrument Inc. (Sarasota, FL, USA) [45].
We observed increases in TEER during the differentiation
stage of pBECs, which reached a statistically significant level
on days 14, 21 and 23–25 (pre-infection) in non-asthmatics
(Additional file 1: Figure S1E), and days 21 and 23–
25 in asthmatics (Additional file 1: Figure S1F). How-
ever, no difference was observed between the TEER of
pBECs from asthmatics compared with no-asthmatics
(Additional file 1: Figure S1E-F).
Expression of candidate miRNAs in pBECs
We initially confirmed that H1N1 IAV (MOIs 0.5, 1, 5
and 10) infection for 24 h had no effect on cell viability
compared with cells incubated with UV-inactivated IAV
H1N1 or media, whereas MOI 20 caused a significant
cell death (Additional file 1: Figure S2). To investigate
the effect of IAV H1N1 on expression of candidate miR-
NAs, pBECs cultured in monolayers or at ALI culture
were infected (MOI 5 [12, 13, 35] for 1 or 6 h, respect-
ively and allowed to recover over 24 h). Changes in ap-
pearance of MDCK cells, including enlarged nuclei and
cellular granulation [46] confirm infection in cells cul-
tured in monolayers from both groups (Additional file 1:
Figure S3). Further, our data show that pBECs from
non-asthmatics cultured at ALI had the same viral ti-
ters as cells from asthmatics 24 h post infection
(Additional file 1: Figure S4 A-B) [34] and indicate
that epithelial cells of non-asthmatics and asthmatics
are infected to the same level.
We further confirmed that RNU44 is expressed in
pBECs, is not affected by disease state (asthma) or
H1N1 infection and hence is an appropriate endogenous
control for miRNAs (Additional file 1: Figure S5). We
also showed that pBECs incubated with UV-inactivated
IAV H1N1 expressed similar levels of miR-20a, − 132
and − 22 as media controls at corresponding time
points and this was consistent in both culture condi-
tions (Additional file 1: Figure S6). Thus, our subse-
quent data from cells infected with IAV H1N1 were
compared with corresponding data from cells cultured
with media.
We initially observed similar expression of miR-20a, −
132, and − 22 in pBECs from asthmatic and non-asthmatics
cultured as monolayers in the absence of any stimulus at
baseline (0 h) (Fig. 1). Thereafter, we infected pBECs cul-
tured as monolayers with IAV H1N1 (MOI 5) and assessed
the expression of candidate miRNAs at different time
points (1, 4, 6 and 24 h). Our data show that expressions of
these miRNAs were not affected to statistically significant
levels by IAV H1N1 infection in cells from either
non-asthmatics or asthmatics, compared with relevant con-
trol. The pattern of expression of these miRNAs was also
similar in both group (Fig. 1).
The baseline expression (0 h) of these miRNAs were
also similar in pBECs from asthmatics and non-asthmatics
when cultured at ALI (Fig. 2). IAV H1N1 infection did not
alter the expression of miR-20a, and − 132 (Fig. 2a-b), in
ALI cultures. miR-22 expression however increased over
time in pBECs from non-asthmatics and reached a statisti-
cally significant level at 24 h compared with 0 and 6 h post
infection (P = 0.015 and P = 0.018 respectively, Fig. 2c). In
contrast, miR-22 expression in pBECs from asthmatics
remained unchanged after infection. The different pattern
of miR-22 expression in pBECs in asthmatics indicates a
potential involvement of this miRNA in epithelial dysregu-
lation after IAV H1N1 infection.
miR-22 mimic suppresses and antagomir induces CD147
and HDAC4 mRNA expression
miR-22 expression is reported as a pro-differentiation
miRNA [22] that regulates the expression of several tar-
gets including CD147 and HDAC4. Both targets have
potential roles in airway remodeling and cell homeosta-
sis [47–49]. To confirm CD147 and HDAC4 are targets
of miR-22, minimally immortalized HBEC-6KT cells
Moheimani et al. Respiratory Research  (2018) 19:145 Page 4 of 16
were transfected with miR-22 mimic (5 nM) or antago-
mir (5 nM) for 24 or 48 h, respectively. No morpho-
logical changes or signs of cell death was observed
during transfection (Additional file 1: Figure S7A).
Transfection was confirmed by assessment of miR-22
expression, using qPCR. Transfecting cells with miR-22
mimic resulted in significantly increased expression of
miR-22 (Additional file 1: Figure S7B) while the antago-
mir inhibited the expression of miR-22 to levels below
detection. Cells transfected with miR-22 mimic expressed
lower levels of both CD147 and HDAC4 mRNA (Add-
itional file 1: Figure S7C-D), whereas those transfected
with miR-22 antagomir expressed higher expression of
both genes (Additional file 1: Figure S7E-F). We observed
no difference in protein expressions of CD147 and
HDAC4 at these time points (data not shown). These data
confirm that CD147 and HDAC4 genes are targets of
miR-22.
To assess the functional role of miR-22, we transfected
pBECs from non-asthmatics and asthmatics cultured as
monolayers with miR-22 mimic (5 nM) for 24 h for
mRNA and 48 h for protein level assessments. Transfec-
tion was confirmed by evaluating the induction of
miR-22 expression in both non-asthmatics (P = 0.014)
and asthmatics (P = 0.014), using qPCR (Fig. 3a-b).
Over-expression of miR-22 suppressed CD147 mRNA
and protein levels in pBECs from non-asthmatics (P =
0.050 and P = 0.014), and asthmatics (P = 0.050 and P =
0.050, Fig. 3c-f ). Over-expression of miR-22 also
suppressed HDAC4 protein levels (P = 0.050) in the
pBECs of non-asthmatics and mRNA levels in asth-
matics (P = 0.050, Fig. 3g-h).
Expression of CD147 and HDAC4 in pBECs from non-
asthmatics and asthmatics cultured at ALI
We next assessed the expression of CD147 and HDAC4
in pBECs grown at ALI following exposure to IAV
H1N1.
Basal (0 h) expression of CD147 at mRNA and protein
levels in pBECs from non-asthmatics and asthmatics
were comparable (Fig. 4). Following IAV H1N1 infec-
tion, expression of CD147 decreased in pBECs of
non-asthmatics over time, 0 vs 8 h (P = 0.008), 0 vs 24 h
(P < 0.0001) and 6 vs 24 h (P = 0.019, Fig. 4a). In con-
trast, CD147 expression increased and reached a signifi-
cant level (P = 0.037) after 24 h compared with 6 h in
pBEC from asthmatics (Fig. 4b). Consequently, expres-
sion of CD147 was significantly higher (P = 0.004) in
pBECs from asthmatics compared with non-asthmatics
at 24 h post infection (Fig. 4a-b). CD147 protein expres-
sion was not affected by IAV H1N1 infection after 24 h
in pBECs from non-asthmatics (Fig. 4c and e) but in-
creased significantly (P = 0.013) in cells from asthmatics
(Fig. 4d and f). Accordingly, CD147 protein levels were
significantly higher (P = 0.014) in pBECs from asth-
matics compared with non-asthmatics at 24 h after IAV
H1N1 infection (Fig. 4e-f ).
We also observed that HDAC4 expression was signifi-
cantly lower (P = 0.004) in pBECs of asthmatics
Fig. 1 Effect of IAV H1N1 infection on miRNA expression in pBECs
from non-asthmatics and asthmatics cultured as monolayers. Cells
were infected with IAV H1N1 (MOI 5) and the expression of
candidate miRNAs were assessed at different time points (0, 1, 4, 6
and 24 h). a miR-20a, (b) miR-132, and (c) miR-22, were expressed at
similar levels in non-asthmatics and asthmatic cells, at baseline (0 h)
or after IAV H1N1 infection (1–24 h), using Kruskal Wallis multiple
comparisons test, N = 5. The cycle threshold (Ct) value was
normalized to that of the RNU44 (ΔCt). Data are presented relative
to corresponding non-asthmatic levels at baseline
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compared with non-asthmatics at baseline (Fig. 5a-b).
Further, HDAC4 expression was suppressed over time
(0–24 h) significantly after IAV H1N1 infection in cells
from non-asthmatics, 0 vs 8 h (P = 0.015), 0 vs 24 h (P <
0.0001) and 6 vs 24 h (P = 0.020, Fig. 5a) but remained
unchanged in asthmatics (Fig. 5b). These led to lower
levels (P = 0.004) of HDAC4 in non-asthmatics com-
pared with asthmatics at 24 h post infection (Fig. 5a-b).
mRNA data match observations with protein levels as
IAV H1N1 infection reduced HDAC4 protein levels
significantly (P = 0.014) at 24 h compared with baseline
in cells from non-asthmatics (Fig. 5c and e). However,
HDAC4 protein expression was not affected by infection
in cells from asthmatics (Fig. 5d and f).
These data show that CD147 and HDAC4 mRNA and
protein levels differ after IAV H1N1 infection in cells
from asthmatics compared with non-asthmatics.
Expression and activity of MMP-9 in pBECs from non-
asthmatics and asthmatics cultured at ALI
CD147 is known to induce matrix metalloproteinase
(MMP) production (e.g. MMP-9) [48]. In addition,
HDAC4 inhibition has been shown to prevent increases
in MMP-9 and hence EMT in a mouse model of
bleomycin-induced acute lung injury [50]. MMP-9 was
reported to be increased in the airways of asthmatics
and to play important multiple roles in tissue remodel-
ing by degrading the extracellular matrix, and inducing
inflammation [51, 52]. We therefore next assessed more
functional aspects of miR-22 targets by measuring the
expression and activity of MMP-9 in pBECs grown at
ALI following IAV H1N1 infection.
Basal levels of MMP-9 mRNA and protein in pBECs
from non-asthmatics were significantly higher compared
with asthmatics (P = 0.004 and P = 0.028, respectively,
Fig. 6a-f ). Following IAV H1N1 infection, mRNA ex-
pression of MMP-9 decreased in pBECs of non-asth-
matics over time at 0 vs 6 h (P = 0.011), 0 vs 8 h (P =
0.004) and 0 vs 24 h (P = 0.007, Fig. 6a). Whereas,
MMP-9 expression increased and reached a significant
level after 24 h compared with 6 h in pBEC from asth-
matics (P = 0.042, Fig. 6b). MMP-9 protein levels
reduced (P = 0.014) after IAV H1N1 infection (24 h) in
pBECs from non-asthmatics (Fig. 6c and e) but were
not affected by infection in cells from asthmatics
(Fig. 6d and f ). Using gelatin zymography we showed
significant decreases in proMMP-9 in basal cell cul-
ture media after IAV H1N1 infection for 6 and 8 h
(0 vs 6 h; P = 0.001 and 0 vs 8 h; P = 0.001) in pBECs of
non-asthmatics (Fig. 6g and i). In contrast, infection
had no effect on proMMP-9 activity in cells from
asthmatics (Fig. 6h and j).
These data indicate that IAV H1N1 infection also has
differential effects on MMP-9 expression in cells from
asthmatics compared with non-asthmatics. Also, MMP-9
expression and activity are congruent with CD147 and
HDAC4 expression in pBECs after infection particularly
in cells from non-asthmatics.
Fig. 2 Effect of IAV H1N1 infection on miRNA expression in pBECs
from non-asthmatics and asthmatics cultured at ALI. Cells were
infected with IAV H1N1 (MOI 5) and the expression of candidate
miRNAs were assessed at different time points (0, 6, 8 and 24 h). a
miR-20a, (b) miR-132, and (c) miR-22, were expressed at similar levels
in non-asthmatics and asthmatic cells, at baseline (0 h). H1N1
infection had no effect on the expression of (a) miR-20a, and (b)
miR-132, whereas (c) miR-22 expression increased after infection in
cells form non-asthmatics but not in asthmatics, *P ≤ 0.05, using the
Kruskal Wallis multiple comparisons test, N = 5. The cycle threshold
(Ct) value was normalized to that of the RNU44 (ΔCt). Data are
presented relative to corresponding non-asthmatic levels at baseline
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Expression of c-Myc and SP1 in pBECs from non-
asthmatics and asthmatics cultured at ALI
In addition to miR-22, c-Myc and SP1 transcription fac-
tors are proposed to regulate CD147 gene transcription
[53]. SP1 has also been reported to regulate HDAC4
[54]. Thus, we next sought to determine the effect of
IAV H1N1 infection on the expression of these tran-
scription factors.
At baseline, no difference was observed in mRNA ex-
pression of c-Myc in pBECs of non-asthmatics compared
Fig. 3 Effect of ectopic miR-22 mimic on CD147 and HDAC4 in pBECs of non-asthmatics and asthmatics. pBECs cultured as monolayers were
transfected with miR-22 mimic (5 nM) for 24 or 48 h. a-b Transfection was confirmed by assessment of miR-22 expression, and the miR-22 mimic
increased miR-22 expression after 24 h in both groups. c-f CD147 mRNA expression was reduced after 24 h in asthmatics and protein expression
was suppressed after 48 h in both group. g-j HDAC4 mRNA expression was reduced in asthmatics after 24 h and protein expression was
suppressed after 48 h in non-asthmatics. *P ≤ 0.05, using Mann-Whitney nonparametric test, N ≥ 3
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to asthmatics (Fig. 7a-b). Following IAV H1N1 infection,
expression of c-Myc reduced compared with baseline; 0 vs
6 h (P = 0.011), 0 vs 8 h (P = 0.008) and 0 vs 24 h (P =
0.003), and remained unchanged during infection (6–
24 h) in pBECs from non-asthmatics (Fig. 7a) whereas its
expression significantly increased (P = 0.006) in cells from
asthmatics at 24 h compared with 6 h (Fig. 7b). Conse-
quently, at 24 h post infection, mRNA expression of
c-Myc was significantly higher (P = 0.015) in pBECs from
asthmatics compared with non-asthmatics (Fig. 7a-b). At
the protein level, IAV H1N1 infection did not affect
c-Myc expression in cells from non-asthmatics (Fig. 7c
and e), but increased c-Myc in asthmatics although not to
a statistically significant level (Fig. 7d and f). We also ob-
served comparable data with the assessment of SP1 ex-
pression at baseline and after IAV H1N1 infection (Fig. 8).
These data suggest that IAV H1N1 infection also has
different effects on c-Myc and SP1 mRNA expression in
cells from asthmatics compared with non-asthmatics,
and that IAV H1N1 induced induction of c-Myc and SP1
may increase CD147 expression in asthmatics.
Discussion
We showed that under basal conditions, the pattern of
miR-20a, − 132 and − 22 expression is similar in pBECs
cultured in monolayer and differentiated ALI conditions,
and are not affected by asthma. Our data support previ-
ous reports by Martinez-Nunez et al., who did not
observe any changes in expression of these miRNAs in
pBECs form non-asthmatics and asthmatics cultured as
monolayers [38], as well as Williams et al., who also re-
ported no significant differences in the expression of
Fig. 4 CD147 expression in pBECs from non-asthmatics and asthmatics cultured at ALI. Cells were infected with IAV H1N1 (MOI 5) and the
expression of CD147 was assessed at different time points. a and (b) represent mRNA expression of CD147 at baseline (0 h) and after IAV H1N1
infection (6–24 h) in non-asthmatics and asthmatics, respectively. The cycle threshold (Ct) value was normalized to 18S gene (ΔCt) and data are
presented relative to corresponding non-asthmatics at baseline. *P≤ 0.05 intra-cohort, and #P ≤ 0.05 inter-cohort at 24 h, using the Kruskal Wallis
multiple comparisons test and Mann-Whitney test, respectively, N=5. c and (d) are immunoblots representative of baseline and 24 h after
infection in non-asthmatics and asthmatics, respectively. e and (f) represent densitometric quantification of immunoblots. Data are presented
relative to corresponding non-asthmatic levels at baseline. *P≤ 0.05 intra-cohort, and #P ≤ 0.05 inter-cohort at 24 h, using Mann-Whitney
test, N=4
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miRNAs in airway biopsies obtained from normal and
mild asthmatic patients [39]. Moreover, IAV H1N1 in-
fection did not affect the expression of these miRNAs
when cells were cultured in submerged monolayers. In
contrast, in cells cultured at the ALI, the kinetics of
miR-22 expression was different after IAV H1N1 infection
in cells from asthmatics compared with non-asthmatics.
Specifically, miR-22 expression increased in pBECs of
non-asthmatics but remained unchanged in asthmatics.
We then found in non-asthmatics, the patterns of miR-22
expression were concomitantly opposite to CD147 gene,
HDAC4 gene and protein, and their downstream MMP-9
gene and protein levels. In contrast, in pBECs from asth-
matics, the expression of CD147 increased but miR-22,
HDAC4 and MMP-9 expression remained unchanged
after infection. To determine the mechanism responsible
for IAV H1N1 induced induction of CD147 in cells from
asthmatics, we further assessed the effect of infection on
other regulatory factors of these candidate target genes.
Our data indicate that IAV H1N1 infection induced
c-Myc and SP1 gene expression in pBECs of asthmatics
which may underpin the increased CD147 levels. In
addition, we confirmed CD147 and HDAC4 are targets of
miR-22. Comparing the effect of ectopic miR-22 mimic
expression on its targets in pBECs of non-asthmatics with
asthmatics showed that miR-22 overexpression suppressed
CD147 in both cohorts whereas HDAC4 was suppressed
at the protein level in non-asthmatics and mRNA level in
asthmatics. These data indicate that miR-22 regulates
CD147 and HDAC4 expression.
No differences were observed in morphology or phys-
ical properties of pBECs between non-asthmatics and
Fig. 5 HDAC4 expression in pBECs from non-asthmatics and asthmatics cultured at ALI. Cells were infected with IAV H1N1 (MOI 5) and HDAC4
expression was assessed at different time points. a and (b) represent mRNA expressions of HDAC4 at baseline and after IAV H1N1 infection
(6–24 h) in non-asthmatics and asthmatics, respectively. The cycle threshold (Ct) value was normalized to 18S gene (ΔCt) and data are presented
relative to corresponding non-asthmatics at baseline. *P ≤ 0.05 intra-cohort, and #P≤ 0.05 inter-cohort between corresponding time points, using
the Kruskal Wallis multiple comparisons test and Mann-Whitney test, respectively, N=5. c and (d) are immunoblots representative of baseline and
24 h after infection in non-asthmatics and asthmatics, respectively. e and (f) represent densitometric quantification of immunoblots. Data are
presented relative to corresponding non-asthmatic levels at baseline. *P ≤ 0.05, using Mann-Whitney test, N=4
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asthmatics cultured as monolayers or at ALI. This is in
agreement with previously reported data by Hackett et
al., who showed that TEER was not different between
pBECs from non-asthmatics and asthmatics [6]. While
we did not assess different cell types or tight junction
complexes, our TEER data were in contrast with Xiao et
al., who showed tight junction and TEER was signifi-
cantly lower in cultures from asthmatics than from
non-asthmatics [55]. This discrepancy may be due to
differences in sample numbers (5 vs 40). Furthermore,
we observed similar levels of infection in pBECs from
both groups at 24 h post infection which support data
reported by Fujimoto et al. [56]. The virus titres in bron-
choalveolar lavage fluid from a mouse model of bron-
chial asthma remained similar to control up to 2 days
post IAV H1N1 infection and reached the highest level
Fig. 6 MMP-9 expression and activity in pBECs from non-asthmatics and asthmatics cultured at ALI. Cells were infected with IAV H1N1 (MOI 5)
and MMP-9 expression was assessed at different time points. a and (b) mRNA expression of MMP-9 at baseline and after IAV H1N1 infection
(6–24 h) in non-asthmatics and asthmatics. The cycle threshold (Ct) value was normalised to the 18S gene (ΔCt) and data are presented relative
to corresponding non-asthmatics at baseline. *P ≤ 0.05 intra-cohort, and #P ≤ 0.05 inter-cohort between corresponding time points, using the
Kruskal Wallis multiple comparisons test and Mann-Whitney test, respectively, N = 5. c and (d) are immunoblots representative of baseline and
24 h after infection in non-asthmatics and asthmatics, respectively. e and (f) Densitometric quantification of MMP-9 immunoblots. Data are
presented relative to corresponding non-asthmatic levels at baseline. *P ≤ 0.05, using non-parametric test, N ≥ 4. g and (h) Representative
zymograms after infection (0–24 h) in non-asthmatics and asthmatics. i and (j) Densitometric quantification of zymograms. Data are presented
relative to corresponding non-asthmatic levels at baseline. *P ≤ 0.05 intra-cohort, and #P ≤ 0.05 inter-cohort between corresponding time points,
using the Kruskal Wallis multiple comparisons test, N = 5
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after 3 days of infection in an asthma model [56]. Des-
pite these similarities, the different pattern of miR-22
expression in epithelial cells of adults with severe asthma
may indicate the potential involvement of this miRNA in
asthma pathogenesis. Our results highlight a novel
mechanism of miR-22 mediated suppression of CD147
and HDAC4 in airway epithelial dysregulation that is as-
sociated with IAV H1N1 infection in severe asthma.
IAV causes significant morbidity and mortality in
annual epidemics [14]. During the 2009 H1N1 swine flu
pandemic in Australia and New Zealand, 33% of individ-
uals who developed severe influenza and were admitted
to hospital or ICU had asthma [57]. While vaccination is
the major protective intervention against IAV H1N1 in-
fection, its efficacy is challenged by new strains and
therefore new vaccines have to be developed annually.
Hence it is critical to understand the underlying mecha-
nisms, such as miRNAs and their targets, responsible for
severe responses of asthmatics to this infection to be
able to provide more efficient interventions. While a
number of miRNAs have been associated with abnor-
malities in asthmatic epithelium and disease progression,
current asthma treatments (e.g. inhaled corticosteroids)
show no major effect on them [39, 58, 59]. Hence, tar-
geting miRNA abnormalities, using specific miRNA
antagomirs or mimics, and restoring their normal func-
tions may be an effective new intervention strategy.
The miR-20a is a member of miR-17-92 cluster which
has essential roles in maintaining the structural homeo-
stasis of the developing lung epithelium [21]. miR-20a is
reported to be increased in the epithelium and mesen-
chyme of the embryonic compared with fully developed
Fig. 7 c-Myc expression in pBECs from non-asthmatics and asthmatics cultured at ALI. Cells were infected with IAV H1N1 (MOI 5) and the
expression of c-Myc was assessed at different time points. a and (b) represent mRNA expression of c-Myc at baseline and after IAV H1N1 infection
(6–24 h) in non-asthmatics and asthmatics, respectively. The cycle threshold (Ct) value was normalized to 18S gene (ΔCt) and data are presented
relative to corresponding non-asthmatics at baseline. *P≤ 0.05 intra-cohort, and #P ≤ 0.05 inter-cohort at 24 h, using the Kruskal Wallis multiple
comparisons test and Mann-Whitney test, respectively, N=5. c and (d) are immunoblots representative of baseline and 24 h after infection in
non-asthmatics and asthmatics, respectively. e and (f) represent densitometric quantification of immunoblots. Data are presented relative to
corresponding non-asthmatic levels at baseline, N = 4
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lung [21]. Our results, however, showed the same base-
line level of miR-20a in pBECs from asthmatics com-
pared with non-asthmatics cultured at both conditions.
In addition, showed that miR-20a was unaffected by IAV
H1N1 infection in pBECs form asthmatics compared
with non-asthmatics in both culture conditions, which
indicate this miRNA may not be responsive to the virus
or its roles in epithelial cell homeostasis are more prom-
inent during lung development.
Our data also showed that miR-132 is expressed at
the same level in epithelial cells of asthmatics and
non-asthmatics at baseline and after IAV H1N1 infec-
tion which was not dependent on culture conditions.
Buggele et al., reported that Infection with IAV A/
Udorn/72 H3N2 and A/WSN/33 H1N1 strains re-
ported to increase miR-132 expression in the human
lung epithelial cell lines A549 and BEAS-2B cells
[26]. miR-132 has been shown to be induced in cells
infected with Kaposi’s sarcoma-associated herpesvirus,
and to target the histone acetyltransferase protein,
p300, which is required for the production of IFNß
[25]. However, we observed no effect of IAV H1N1
infection on miR-132 in epithelial cells from non-
asthmatics or asthmatics in both culture conditions.
These discrepancies could be due to the nature of
cells; primary versus cell-line, or different strains of
IAV A/Auckland/1/2009 H1N1 versus A/Udorn/72
H3N2 and A/WSN/33 H1N1.
Despite similar expression of miR-22 at baseline, our
data indicate that after IAV H1N1 infection expression
of this miRNA increased in pBECs of non-asthmatics
whereas it was not altered in pBECs of asthmatics.
Fig. 8 SP1 expression in pBECs from non-asthmatics and asthmatics cultured at ALI. Cells were infected with IAV H1N1 (MOI 5) and SP1
expression was assessed at different time points. a and (b) represent mRNA expression of SP1 at baseline and after IAV H1N1 infection (6–24 h) in
non-asthmatics and asthmatics, respectively. The cycle threshold (Ct) value was normalized to 18S gene (ΔCt) and data are presented relative to
corresponding non-asthmatics at baseline. *P≤ 0.05 intra-cohort, and #P ≤ 0.05 inter-cohort at 24 h, using Kruskal Wallis multiple comparisons test
and Mann-Whitney test, respectively, N=5. c and (d) are immunoblots representative of baseline and 24 h after infection in non-asthmatics and
asthmatics, respectively. e and (f) represent densitometric quantification of immunoblots. Data are presented relative to corresponding non-
asthmatic levels at baseline, N = 4
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miR-22 has been proposed to have tumor suppressive
effects by targeting different genes responsible for cell
proliferation [22, 23]. One of the targets of miR-22 is
CD147 (EMMPRIN/basigin/HAb18G), which has a key
role in tumor progression and metastasis [53]. CD147
induces the production of matrix metalloproteinases
(MMP) such as MMP-9 that has important roles in
airway remodeling and inflammation [48]. Patients with
severe asthma are reported to have increased levels and
activity of MMP-9 in their sputum compared with mild
asthmatics and normal subjects [60]. Also, MMP-9 was
shown to increase in airway epithelial cells in a mouse
model of airway remodeling induced by ovalbumin chal-
lenge [52]. Furthermore, Jouneau et al., reported that
epithelial cells are the major source for CD147 com-
pared with alveolar and blood monocytes [48]. Another
downstream target of miR-22 is HDAC4 [47]. HDAC4 is
a key member of class IIa HDACs which plays an im-
portant role in tissue growth and development [61].
HDAC4 is known to be involved with TGF-ß1 induced
epithelial-mesenchymal transition (EMT) in lung epithe-
lial cells [49]. EMT is defined as a process that epithelial
cells lose polarity and intercellular contacts, and adopt a
mesenchymal phenotype. These changes are character-
ized by repression of epithelial genes, such as E-cadherin
and ZO-1, and increased expression of mesenchymal
proteins, including fibronectin, vimentin, and α-smooth
muscle actin [33]. EMT can also lead to tissue remodel-
ing and inflammation [49]. pBECs treated with TGF-ß1
also showed increased MMP-9 activity in cell culture
supernatant [62]. There is evidence that epithelial cells
of asthmatics are more prone to EMT [31]. Blocking
HDAC4 reported to suppress TGF-ß1 associated in-
ductions of α-smooth muscle actin, fibronectin and
vimentin while restore TGF-ß1 related suppression of
E-cadherin and TGF-ß1 induced migration of lung
epithelial cells [49]. In addition, inhibiting HDAC4
suppressed MMP-9 elevation and hence EMT in a
mouse model of bleomycin-induced acute lung injury
[50]. Hence, MMP-9 is an important downstream
factor of both CD147 and HDAC4 activity that is
associated with tissue remodeling directly and via
EMT processes.
Our data on MMP-9 expression are particularly inter-
esting. To our knowledge there are no previous reports
comparing MMP-9 expression in epithelial cells from
asthmatics with non-asthmatics. MMP-9 mRNA and
protein were expressed at lower levels in epithelial cells
from asthmatics compared with non-asthmatics. How-
ever, it was previously shown that significant increases
in MMP-9 in bronchoalveolar lavage positively corre-
lated with levels of eosinophils and neutrophils in asth-
matics compared with non-asthmatics [63]. These
discrepancies may arise from the absence of other cells
and hence lack of cell to cell communication in our
model.
We showed that differential patterns of miR-22 ex-
pression may be a control factor to regulate CD147 and
HDAC4 expression and their downstream MMP-9
expression and hence associated airway remodeling after
IAV H1N1 infection in non-asthmatics. After infection,
CD147, HDAC4 and MMP-9 mRNA levels reduced over
time in association with increased miR-22 expression
which prevents CD147 protein induction by maintaing
its levels unchanged, and reduces HDAC4 and
MMP-9 protein levels after infection in pBECs from
non-asthmatics. However, these mechanisms differ in
epithelial cells of asthmatics. Although miR-22 ex-
pression was not affected by IAV H1N1 in cells from
asthmatics, CD147 increased at both gene and protein
levels, potentially driven by infection induced c-Myc
and SP1 expression, whereas HDAC4 and their down-
stream target MMP-9 remained unchanged thus, po-
tentially promoting airway remodeling. Overexpression
of miR-22 in pBECs of asthmatics significantly suppressed
CD147 expression. The miR-22 mimic may therefore offer
some potential protective role by reversing CD147 over
expression after IAV H1N1 infection in asthmatics to pre-
vent further tissue remodeling.
Interestingly, IAV H1N1 infection showed no effect on
miR-22 expression in cells in basal monolayers from
asthmatics or non-asthmatics confirming that its effect
is associated with differentiated cells. As for why the
miR-22 pattern of expression differs in epithelial cells
from asthmatics compared with non-asthmatics after in-
fection, further molecular investigations are required
and it is necessary to determine the effect of IAV on
different cells types between two groups. Our data so far
may imply that there is a recovery mechanism after IAV
H1N1 infection in differentiated cells from non-asth-
matics which leads to increase in miR-22 which is not
present in asthmatics.
Due to the nature of exacerbations of asthma, investi-
gating the epigenetic regulatory mechanisms within the
airway epithelium is technically difficult, especially in
response to specific exposures such as IAV. While the
use of pseudostratified ALI epithelial cultures has several
advantages over monolayer cultures, our study has
limitations. One is that we only compared the pBECs at
ALI culture of five subjects with asthma and five
non-asthmatics. Regardless of the limitations in patient
numbers, they were well-phenotyped. Another limitation
is that we only investigated targeted miRNAs with differ-
ent biological roles. However, miRNAs form networks
and many of which have multiple binding partners and
therefore affect multiple pathways. Thus, our next
approach will be to assess global miRNAs and corre-
sponding mRNA targets with high accuracy in our
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samples, using next gene sequencing technology. Fur-
thermore, in our model, pBECs at passage 2 were differ-
entiated over 23–25 days and during this period cell
media was refreshed frequently. The effect of adminis-
tered inhaled corticosteroids by patients was washed out
during this process. However, to our knowledge there
are no reports of the effects of common asthma thera-
peutics (e.g. corticosteroids) on miRNA expression in
airway epithelial cells during IAV infection which war-
rants future investigations. Another limitation is that we
did not assess which cell type was most infected with
IAV H1N1 when cells were cultured at ALI conditions
since we extracted miRNA, mRNA and protein from en-
tire cell populations. However, this and how it affects
miRNA expression in different cells (e.g. ciliated cells vs
basal cells) will be interesting to determine. In addition,
in our infection model, only MOI of 5 of IAV H1N1 was
used. Future assessments on infection with IAV H1N1 at
multiple MOIs (e.g. 0.5, 1, 5 and 10) will provide more
evidence on regulation of miR-22 and its targets by this
infection in pBECs. Also, administration of specific
inhibitors of c-Myc or SP-1 during infection in cells
from both groups, will determine the regulatory roles of
these transcription factors on CD147 and HDAC4 in
epithelial cells. Further, we assessed miRNA expression
and their functions only in pBECs with or without infec-
tion, whereas co-culturing epithelial cells with relevant
cells, e.g. neutrophils or macrophages which are also a
source of MMP-9 in asthmatics [48], may affect miRNA
expression and/or their targets in epithelial cells due to
cell to cell crosstalk. Finally, our time course for IAV
H1N1 infection was limited to 24 h.
Conclusions
In conclusion, we demonstrate that in the absence of
any stimulus, there is no difference in candidate miR-
NAs expressions between monolayer and ALI culture
conditions. However, different cultures of epithelial cells
respond differently to IAV H1N1 infection. We detect
miR-22 and its targets CD147 and HDAC4 as potential
responses to IAV H1N1 infection in epithelial cells with
different patterns of expression in asthmatics compared
with non-asthmatics. Our outcomes highlight a new
response, which may potentiate airway remodeling asso-
ciated with H1N1 infection in severe asthma.
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